CooperVision is highlighting its growing global leadership in myopia management at this week’s 2025 American Academy of Optometry annual meeting in Boston. The company has published a comprehensive global impact report detailing the critical role of MiSight® 1 day contact lenses in addressing myopia.1 It will also present new scientific findings that expand understanding of myopia progression and receive recognition for the widespread impact of its published research.
Redefining What’s Possible in Myopia Care
“We’re not just responding to a global challenge—we’re redefining what’s possible in myopia care,” said Steven Robins, President, Americas, CooperVision. “Our work is already changing the lives of more than 200,000 children worldwide, and we’re just getting started.2,3 Academy 2025 is a powerful platform to share our progress, spark new collaborations, and accelerate a future where myopia’s impact is dramatically reduced.”
Drawing on cross-regional data and collaborations with leading researchers and eye care professionals (ECPs), the Progress in Focus: The Global Impact of MiSight® 1 day4 report delivers the most comprehensive view to date of myopia’s global implications and the measurable difference MiSight® 1 day has made on children’s lives.1 It highlights advances in awareness, clinical adoption, and patient outcomes, underscoring CooperVision’s leadership and influence while celebrating past achievements and charting the path forward.
CooperVision Honored with Prestigious 2025 Garland W. Clay Award
CooperVision is complementing the report by presenting a slate of myopia-specific scientific papers, posters, and sponsored lectures. Highlights include research into a novel approach to assessing spectacle-wearing compliance in myopic children,5 trends in pre-myopia development and management,6 and the long-term impact of daily disposable hydrogel contact lenses on corneal and epithelial thickness in children,7 as well as practical guidance for ECPs practicing myopia management.
As a capstone to its Academy presence, CooperVision scientists and their coauthors will be honored with the prestigious 2025 Garland W. Clay Award, given annually to the author(s) of the most cited paper published in Optometry and Vision Science (OVS) during the preceding five years. “Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial” (Chamberlain P et al.) is available via Open Access. This is the second installment in the trilogy of landmark MiSight® 1 day study publications, joining the three-year paper (the 2021 Garland W. Clay honoree) and seven-year paper,1,8,9 all published in OVS.
Discover More About Academy 2025
For more details about Academy 2025, visit https://aaopt.org/meetings/academy-2025-boston.
